An active metabolite of tetrabenazine
Related Products
Isomer(s)
42116NBI 98782
Parent Compound(s)
20380Tetrabenazine
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Dihydrotetrabenazine

Item No. 27182

Technical Information
Formal Name
1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-2H-benzo[a]quinolizin-2-ol
CAS Number
3466-75-9
Synonyms
  • DTBZ
  • trans-(2,3)-Dihydro Tetrabenazine
Molecular Formula
C19H29NO3
Formula Weight
Purity
≥98% (mixture of isomers)
A solid
Chloroform: solubleMethanol: soluble
SMILES
OC1C(CC(C)C)CN2C(C(C=C(OC)C(OC)=C3)=C3CC2)C1
InChi Code
InChI=1S/C19H29NO3/c1-12(2)7-14-11-20-6-5-13-8-18(22-3)19(23-4)9-15(13)16(20)10-17(14)21/h8-9,12,14,16-17,21H,5-7,10-11H2,1-4H3
InChi Key
WEQLWGNDNRARGE-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Product Description

    Dihydrotetrabenazine is an active metabolite of the vesicular monoamine transporter 2 (VMAT2) inhibitor tetrabenazine (Item No. 20380) that is generated by hepatic carbonyl reductases.1 Dihydrotetrabenazine binds to mouse pons medulla, hypothalamus, and striatum (Kds = 2.72, 2.28, and 2.4 nM, respectively) and inhibits synaptic vesicular serotonin (5-HT) uptake (IC50s = 2.2, 2.8, and 2.3 nM, respectively).2 It also binds to human caudate nucleus, hippocampus, and substantia nigra pars compacta (Kds = 2.9, 2.5, and 2.8 nM, respectively).3 Dihydrotetrabenazine stereoisomers bind to VMAT2 in rat striatum.4

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Chen, J.J., Ondo, W.G., Dashtipour, K., et alTetrabenazine for the treatment of hyperkinetic movement disorders: A review of the literature. Clin. Ther. 34(7), 1487-1504 (2012).

    2. Scherman, D. Dihydrotetrabenazine binding and monoamine uptake in mouse brain regions. J. Neurochem. 47(2), 331-339 (1986).

    3. Scherman, D., Raisman, R., Ploska, A., et al[3H]dihydrotetrabenazine, a new in vitro monoaminergic probe for human brain. J. Neurochem. 50(4), 1131-1136 (1988).

    4. Yao, Z., Wei, X., Wu, X., et alPreparation and evaluation of tetrabenazine enantiomers and all eight stereoisomers of dihydrotetrabenazine as VMAT2 inhibitors. Eur. J. Med. Chem. 46(5), 1841-1848 (2011).